Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 5, 2014, Pages 619-624

  Espiritu, Patrick N ^a   Sverrisson, Einar F ^a   Sexton, Wade J ^a   Pow Sang, Julio M ^a   Poch, Michael A ^a   Dhillon, Jasreman ^a   Spiess, Philippe E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Pathology; Recurrence; Risk factors; Tumor size; Upper tract urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CUFF RESECTION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; NEPHRECTOMY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; URETER; UROLOGIC NEOPLASMS; UROTHELIUM;

AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84902540457     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.11.006     Document Type: Article

References (16)

1. Cha E.K., Shariat S.F., Kormaksson M., et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2012, 61:818-825.
2. Berger A., Haber G.P., Kamoi K., et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. J Urol 2008, 180:849-854. [discussion 54].
3. Ozsahin M., Zouhair A., Villa S., et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 1999, 35:738-743.
4. Adibi M., Youssef R., Shariat S.F., et al. Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol 2012, 19:1060-1066.
5. Kates M., Badalato G.M., Gupta M., McKiernan J.M. Secondary bladder cancer after upper tract urothelial carcinoma in the US population. BJU Int 2012, 110:1325-1329.
6. Pieras E., Frontera G., Ruiz X., Vicens A., Ozonas M., Piza P. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 2010, 106:1319-1323.
7. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000, 163:73-78.
8. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49:466-477. [discussion 75-7].
9. Rao S.R., Correa J.J., Sexton W.J., et al. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. BJU Int 2012, 110:E475-E480.
10. Greene F.L. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual 2002, Springer-Verlag, New York. 6th ed.
11. Montironi R., Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005, 13:143-153.
12. Protocol for the Examination of Specimens From Patients With Carcinoma of the Ureter and Renal Pelvis Version 3.2.0.0. College of American Pathologists, 2012. Available at: 〈〉 2013 [accessed 06.02.13]. http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2012/RenalPelvUreter_12protocol_3200.pdf.
13. Raman J.D., Messer J., Sielatycki J.A., Hollenbeak C.S. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int 2011, 107:1059-1064.
14. Simone G., Papalia R., Loreto A., Leonardo C., Sentinelli S., Gallucci M. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int 2009, 103:1052-1057.
15. Cho K.S., Hong S.J., Cho N.H., Choi Y.D. Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology 2007, 70:662-666.
16. Capitanio U., Shariat S.F., Isbarn H., et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 2009, 56:1-9.